drugset / Trial / NCT02517099

Preschool Wheeze: Inflammation/Infection Guided Management

NCT02517099

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a single-centre, randomised-controlled trial, comparing management of preschool wheeze. It specifically aims to compare management of preschool wheeze using current clinical guidelines to management determined by eosinophilic inflammation and infection. Participants will be children aged 1-5 years who have recurrent wheezing and will be allocated to one of two treatment groups, either current clinical care or pathological phenotype based management. They will be asked to make 2 study visits to the Royal Brompton Hospital over the course of 4 months.

Timeline

Start
2015-06-05
Primary completion
2018-08-17
Completion
2018-08-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 0.3 unknown
Comparator Azithromycin Small molecule 10 mg/kg
Comparator Beclomethasone Small molecule 200 ug Inhaled

Indications